カテゴリー： Market Monitor Global, 世界, 医療/バイオ

薬剤溶出型冠動脈ステントシステムのグローバル市場展望 2023年-2029年：非生分解性ステント、生分解性ステント

◆英語タイトル：Drug-Eluting Coronary Stent System Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23DC13010）

◆商品コード：MMG23DC13010
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年12月
◆ページ数：112
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医療機器＆消耗品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の薬剤溶出型冠動脈ステントシステム市場規模と予測を収録しています。・世界の薬剤溶出型冠動脈ステントシステム市場：売上、2018年-2023年、2024年-2029年
・世界の薬剤溶出型冠動脈ステントシステム市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の薬剤溶出型冠動脈ステントシステム市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「非生分解性ステント」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

薬剤溶出型冠動脈ステントシステムのグローバル主要企業は、Medtronic、 Abbott、 Cook Medical、 Biotronik、 Terumo、 Boston Scientific、 B. Braun、 STENTYS SA、 MicroPort、 Cordis、 BD、 Sorin Group、 SMT、 LifeTech Scientific Corporation、 Lepu Medical Technology(Beijing)Co.,Ltd.、 JW Medical Systems LTD.、 Sino Medical Sciences Technology Inc.などです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、薬剤溶出型冠動脈ステントシステムのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の薬剤溶出型冠動脈ステントシステム市場：タイプ別、2018年-2023年、2024年-2029年
世界の薬剤溶出型冠動脈ステントシステム市場：タイプ別市場シェア、2022年
・非生分解性ステント、生分解性ステント

世界の薬剤溶出型冠動脈ステントシステム市場：用途別、2018年-2023年、2024年-2029年
世界の薬剤溶出型冠動脈ステントシステム市場：用途別市場シェア、2022年
・直販、流通

世界の薬剤溶出型冠動脈ステントシステム市場：地域・国別、2018年-2023年、2024年-2029年
世界の薬剤溶出型冠動脈ステントシステム市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における薬剤溶出型冠動脈ステントシステムのグローバル売上、2018年-2023年
・主要企業における薬剤溶出型冠動脈ステントシステムのグローバル売上シェア、2022年
・主要企業における薬剤溶出型冠動脈ステントシステムのグローバル販売量、2018年-2023年
・主要企業における薬剤溶出型冠動脈ステントシステムのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Medtronic、 Abbott、 Cook Medical、 Biotronik、 Terumo、 Boston Scientific、 B. Braun、 STENTYS SA、 MicroPort、 Cordis、 BD、 Sorin Group、 SMT、 LifeTech Scientific Corporation、 Lepu Medical Technology(Beijing)Co.,Ltd.、 JW Medical Systems LTD.、 Sino Medical Sciences Technology Inc.

*************************************************************

・調査・分析レポートの概要
薬剤溶出型冠動脈ステントシステム市場の定義
市場セグメント
世界の薬剤溶出型冠動脈ステントシステム市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の薬剤溶出型冠動脈ステントシステム市場規模
世界の薬剤溶出型冠動脈ステントシステム市場規模：2022年 VS 2029年
世界の薬剤溶出型冠動脈ステントシステム市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの薬剤溶出型冠動脈ステントシステムの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の薬剤溶出型冠動脈ステントシステム製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：非生分解性ステント、生分解性ステント
薬剤溶出型冠動脈ステントシステムのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：直販、流通
薬剤溶出型冠動脈ステントシステムの用途別グローバル売上・予測

・地域別市場分析
地域別薬剤溶出型冠動脈ステントシステム市場規模 2022年と2029年
地域別薬剤溶出型冠動脈ステントシステム売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Medtronic、 Abbott、 Cook Medical、 Biotronik、 Terumo、 Boston Scientific、 B. Braun、 STENTYS SA、 MicroPort、 Cordis、 BD、 Sorin Group、 SMT、 LifeTech Scientific Corporation、 Lepu Medical Technology(Beijing)Co.,Ltd.、 JW Medical Systems LTD.、 Sino Medical Sciences Technology Inc.
...

This research report provides a comprehensive analysis of the Drug-Eluting Coronary Stent System market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Drug-Eluting Coronary Stent System market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Drug-Eluting Coronary Stent System, challenges faced by the industry, and potential opportunities for market players.
The global Drug-Eluting Coronary Stent System market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Drug-Eluting Coronary Stent System market presents opportunities for various stakeholders, including Direct sales, Distribution. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Drug-Eluting Coronary Stent System market. Additionally, the growing consumer demand present avenues for market expansion.
The global Drug-Eluting Coronary Stent System market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Drug-Eluting Coronary Stent System market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Drug-Eluting Coronary Stent System market.
Market Overview: The report provides a comprehensive overview of the Drug-Eluting Coronary Stent System market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Non-Biodegradable Stents, Biodegradable Stents), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Drug-Eluting Coronary Stent System market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Drug-Eluting Coronary Stent System market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Drug-Eluting Coronary Stent System market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Drug-Eluting Coronary Stent System market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Drug-Eluting Coronary Stent System market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Drug-Eluting Coronary Stent System market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Drug-Eluting Coronary Stent System, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Drug-Eluting Coronary Stent System market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Drug-Eluting Coronary Stent System market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Non-Biodegradable Stents
Biodegradable Stents
Market segment by Application
Direct sales
Distribution
Global Drug-Eluting Coronary Stent System Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Medtronic
Abbott
Cook Medical
Biotronik
Terumo
Boston Scientific
B. Braun
STENTYS SA
MicroPort
Cordis
BD
Sorin Group
SMT
LifeTech Scientific Corporation
Lepu Medical Technology(Beijing)Co.,Ltd.
JW Medical Systems LTD.
Sino Medical Sciences Technology Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Drug-Eluting Coronary Stent System, market overview.
Chapter 2: Global Drug-Eluting Coronary Stent System market size in revenue and volume.
Chapter 3: Detailed analysis of Drug-Eluting Coronary Stent System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Drug-Eluting Coronary Stent System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Drug-Eluting Coronary Stent System capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Drug-Eluting Coronary Stent System Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Drug-Eluting Coronary Stent System Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Drug-Eluting Coronary Stent System Overall Market Size
2.1 Global Drug-Eluting Coronary Stent System Market Size: 2022 VS 2029
2.2 Global Drug-Eluting Coronary Stent System Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Drug-Eluting Coronary Stent System Sales: 2018-2029
3 Company Landscape
3.1 Top Drug-Eluting Coronary Stent System Players in Global Market
3.2 Top Global Drug-Eluting Coronary Stent System Companies Ranked by Revenue
3.3 Global Drug-Eluting Coronary Stent System Revenue by Companies
3.4 Global Drug-Eluting Coronary Stent System Sales by Companies
3.5 Global Drug-Eluting Coronary Stent System Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Drug-Eluting Coronary Stent System Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Drug-Eluting Coronary Stent System Product Type
3.8 Tier 1, Tier 2 and Tier 3 Drug-Eluting Coronary Stent System Players in Global Market
3.8.1 List of Global Tier 1 Drug-Eluting Coronary Stent System Companies
3.8.2 List of Global Tier 2 and Tier 3 Drug-Eluting Coronary Stent System Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Drug-Eluting Coronary Stent System Market Size Markets, 2022 & 2029
4.1.2 Non-Biodegradable Stents
4.1.3 Biodegradable Stents
4.2 By Type – Global Drug-Eluting Coronary Stent System Revenue & Forecasts
4.2.1 By Type – Global Drug-Eluting Coronary Stent System Revenue, 2018-2023
4.2.2 By Type – Global Drug-Eluting Coronary Stent System Revenue, 2024-2029
4.2.3 By Type – Global Drug-Eluting Coronary Stent System Revenue Market Share, 2018-2029
4.3 By Type – Global Drug-Eluting Coronary Stent System Sales & Forecasts
4.3.1 By Type – Global Drug-Eluting Coronary Stent System Sales, 2018-2023
4.3.2 By Type – Global Drug-Eluting Coronary Stent System Sales, 2024-2029
4.3.3 By Type – Global Drug-Eluting Coronary Stent System Sales Market Share, 2018-2029
4.4 By Type – Global Drug-Eluting Coronary Stent System Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Drug-Eluting Coronary Stent System Market Size, 2022 & 2029
5.1.2 Direct sales
5.1.3 Distribution
5.2 By Application – Global Drug-Eluting Coronary Stent System Revenue & Forecasts
5.2.1 By Application – Global Drug-Eluting Coronary Stent System Revenue, 2018-2023
5.2.2 By Application – Global Drug-Eluting Coronary Stent System Revenue, 2024-2029
5.2.3 By Application – Global Drug-Eluting Coronary Stent System Revenue Market Share, 2018-2029
5.3 By Application – Global Drug-Eluting Coronary Stent System Sales & Forecasts
5.3.1 By Application – Global Drug-Eluting Coronary Stent System Sales, 2018-2023
5.3.2 By Application – Global Drug-Eluting Coronary Stent System Sales, 2024-2029
5.3.3 By Application – Global Drug-Eluting Coronary Stent System Sales Market Share, 2018-2029
5.4 By Application – Global Drug-Eluting Coronary Stent System Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Drug-Eluting Coronary Stent System Market Size, 2022 & 2029
6.2 By Region – Global Drug-Eluting Coronary Stent System Revenue & Forecasts
6.2.1 By Region – Global Drug-Eluting Coronary Stent System Revenue, 2018-2023
6.2.2 By Region – Global Drug-Eluting Coronary Stent System Revenue, 2024-2029
6.2.3 By Region – Global Drug-Eluting Coronary Stent System Revenue Market Share, 2018-2029
6.3 By Region – Global Drug-Eluting Coronary Stent System Sales & Forecasts
6.3.1 By Region – Global Drug-Eluting Coronary Stent System Sales, 2018-2023
6.3.2 By Region – Global Drug-Eluting Coronary Stent System Sales, 2024-2029
6.3.3 By Region – Global Drug-Eluting Coronary Stent System Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Drug-Eluting Coronary Stent System Revenue, 2018-2029
6.4.2 By Country – North America Drug-Eluting Coronary Stent System Sales, 2018-2029
6.4.3 US Drug-Eluting Coronary Stent System Market Size, 2018-2029
6.4.4 Canada Drug-Eluting Coronary Stent System Market Size, 2018-2029
6.4.5 Mexico Drug-Eluting Coronary Stent System Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Drug-Eluting Coronary Stent System Revenue, 2018-2029
6.5.2 By Country – Europe Drug-Eluting Coronary Stent System Sales, 2018-2029
6.5.3 Germany Drug-Eluting Coronary Stent System Market Size, 2018-2029
6.5.4 France Drug-Eluting Coronary Stent System Market Size, 2018-2029
6.5.5 U.K. Drug-Eluting Coronary Stent System Market Size, 2018-2029
6.5.6 Italy Drug-Eluting Coronary Stent System Market Size, 2018-2029
6.5.7 Russia Drug-Eluting Coronary Stent System Market Size, 2018-2029
6.5.8 Nordic Countries Drug-Eluting Coronary Stent System Market Size, 2018-2029
6.5.9 Benelux Drug-Eluting Coronary Stent System Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Drug-Eluting Coronary Stent System Revenue, 2018-2029
6.6.2 By Region – Asia Drug-Eluting Coronary Stent System Sales, 2018-2029
6.6.3 China Drug-Eluting Coronary Stent System Market Size, 2018-2029
6.6.4 Japan Drug-Eluting Coronary Stent System Market Size, 2018-2029
6.6.5 South Korea Drug-Eluting Coronary Stent System Market Size, 2018-2029
6.6.6 Southeast Asia Drug-Eluting Coronary Stent System Market Size, 2018-2029
6.6.7 India Drug-Eluting Coronary Stent System Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Drug-Eluting Coronary Stent System Revenue, 2018-2029
6.7.2 By Country – South America Drug-Eluting Coronary Stent System Sales, 2018-2029
6.7.3 Brazil Drug-Eluting Coronary Stent System Market Size, 2018-2029
6.7.4 Argentina Drug-Eluting Coronary Stent System Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Drug-Eluting Coronary Stent System Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Drug-Eluting Coronary Stent System Sales, 2018-2029
6.8.3 Turkey Drug-Eluting Coronary Stent System Market Size, 2018-2029
6.8.4 Israel Drug-Eluting Coronary Stent System Market Size, 2018-2029
6.8.5 Saudi Arabia Drug-Eluting Coronary Stent System Market Size, 2018-2029
6.8.6 UAE Drug-Eluting Coronary Stent System Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Medtronic
7.1.1 Medtronic Company Summary
7.1.2 Medtronic Business Overview
7.1.3 Medtronic Drug-Eluting Coronary Stent System Major Product Offerings
7.1.4 Medtronic Drug-Eluting Coronary Stent System Sales and Revenue in Global (2018-2023)
7.1.5 Medtronic Key News & Latest Developments
7.2 Abbott
7.2.1 Abbott Company Summary
7.2.2 Abbott Business Overview
7.2.3 Abbott Drug-Eluting Coronary Stent System Major Product Offerings
7.2.4 Abbott Drug-Eluting Coronary Stent System Sales and Revenue in Global (2018-2023)
7.2.5 Abbott Key News & Latest Developments
7.3 Cook Medical
7.3.1 Cook Medical Company Summary
7.3.2 Cook Medical Business Overview
7.3.3 Cook Medical Drug-Eluting Coronary Stent System Major Product Offerings
7.3.4 Cook Medical Drug-Eluting Coronary Stent System Sales and Revenue in Global (2018-2023)
7.3.5 Cook Medical Key News & Latest Developments
7.4 Biotronik
7.4.1 Biotronik Company Summary
7.4.2 Biotronik Business Overview
7.4.3 Biotronik Drug-Eluting Coronary Stent System Major Product Offerings
7.4.4 Biotronik Drug-Eluting Coronary Stent System Sales and Revenue in Global (2018-2023)
7.4.5 Biotronik Key News & Latest Developments
7.5 Terumo
7.5.1 Terumo Company Summary
7.5.2 Terumo Business Overview
7.5.3 Terumo Drug-Eluting Coronary Stent System Major Product Offerings
7.5.4 Terumo Drug-Eluting Coronary Stent System Sales and Revenue in Global (2018-2023)
7.5.5 Terumo Key News & Latest Developments
7.6 Boston Scientific
7.6.1 Boston Scientific Company Summary
7.6.2 Boston Scientific Business Overview
7.6.3 Boston Scientific Drug-Eluting Coronary Stent System Major Product Offerings
7.6.4 Boston Scientific Drug-Eluting Coronary Stent System Sales and Revenue in Global (2018-2023)
7.6.5 Boston Scientific Key News & Latest Developments
7.7 B. Braun
7.7.1 B. Braun Company Summary
7.7.2 B. Braun Business Overview
7.7.3 B. Braun Drug-Eluting Coronary Stent System Major Product Offerings
7.7.4 B. Braun Drug-Eluting Coronary Stent System Sales and Revenue in Global (2018-2023)
7.7.5 B. Braun Key News & Latest Developments
7.8 STENTYS SA
7.8.1 STENTYS SA Company Summary
7.8.2 STENTYS SA Business Overview
7.8.3 STENTYS SA Drug-Eluting Coronary Stent System Major Product Offerings
7.8.4 STENTYS SA Drug-Eluting Coronary Stent System Sales and Revenue in Global (2018-2023)
7.8.5 STENTYS SA Key News & Latest Developments
7.9 MicroPort
7.9.1 MicroPort Company Summary
7.9.2 MicroPort Business Overview
7.9.3 MicroPort Drug-Eluting Coronary Stent System Major Product Offerings
7.9.4 MicroPort Drug-Eluting Coronary Stent System Sales and Revenue in Global (2018-2023)
7.9.5 MicroPort Key News & Latest Developments
7.10 Cordis
7.10.1 Cordis Company Summary
7.10.2 Cordis Business Overview
7.10.3 Cordis Drug-Eluting Coronary Stent System Major Product Offerings
7.10.4 Cordis Drug-Eluting Coronary Stent System Sales and Revenue in Global (2018-2023)
7.10.5 Cordis Key News & Latest Developments
7.11 BD
7.11.1 BD Company Summary
7.11.2 BD Business Overview
7.11.3 BD Drug-Eluting Coronary Stent System Major Product Offerings
7.11.4 BD Drug-Eluting Coronary Stent System Sales and Revenue in Global (2018-2023)
7.11.5 BD Key News & Latest Developments
7.12 Sorin Group
7.12.1 Sorin Group Company Summary
7.12.2 Sorin Group Business Overview
7.12.3 Sorin Group Drug-Eluting Coronary Stent System Major Product Offerings
7.12.4 Sorin Group Drug-Eluting Coronary Stent System Sales and Revenue in Global (2018-2023)
7.12.5 Sorin Group Key News & Latest Developments
7.13 SMT
7.13.1 SMT Company Summary
7.13.2 SMT Business Overview
7.13.3 SMT Drug-Eluting Coronary Stent System Major Product Offerings
7.13.4 SMT Drug-Eluting Coronary Stent System Sales and Revenue in Global (2018-2023)
7.13.5 SMT Key News & Latest Developments
7.14 LifeTech Scientific Corporation
7.14.1 LifeTech Scientific Corporation Company Summary
7.14.2 LifeTech Scientific Corporation Business Overview
7.14.3 LifeTech Scientific Corporation Drug-Eluting Coronary Stent System Major Product Offerings
7.14.4 LifeTech Scientific Corporation Drug-Eluting Coronary Stent System Sales and Revenue in Global (2018-2023)
7.14.5 LifeTech Scientific Corporation Key News & Latest Developments
7.15 Lepu Medical Technology(Beijing)Co.,Ltd.
7.15.1 Lepu Medical Technology(Beijing)Co.,Ltd. Company Summary
7.15.2 Lepu Medical Technology(Beijing)Co.,Ltd. Business Overview
7.15.3 Lepu Medical Technology(Beijing)Co.,Ltd. Drug-Eluting Coronary Stent System Major Product Offerings
7.15.4 Lepu Medical Technology(Beijing)Co.,Ltd. Drug-Eluting Coronary Stent System Sales and Revenue in Global (2018-2023)
7.15.5 Lepu Medical Technology(Beijing)Co.,Ltd. Key News & Latest Developments
7.16 JW Medical Systems LTD.
7.16.1 JW Medical Systems LTD. Company Summary
7.16.2 JW Medical Systems LTD. Business Overview
7.16.3 JW Medical Systems LTD. Drug-Eluting Coronary Stent System Major Product Offerings
7.16.4 JW Medical Systems LTD. Drug-Eluting Coronary Stent System Sales and Revenue in Global (2018-2023)
7.16.5 JW Medical Systems LTD. Key News & Latest Developments
7.17 Sino Medical Sciences Technology Inc.
7.17.1 Sino Medical Sciences Technology Inc. Company Summary
7.17.2 Sino Medical Sciences Technology Inc. Business Overview
7.17.3 Sino Medical Sciences Technology Inc. Drug-Eluting Coronary Stent System Major Product Offerings
7.17.4 Sino Medical Sciences Technology Inc. Drug-Eluting Coronary Stent System Sales and Revenue in Global (2018-2023)
7.17.5 Sino Medical Sciences Technology Inc. Key News & Latest Developments
8 Global Drug-Eluting Coronary Stent System Production Capacity, Analysis
8.1 Global Drug-Eluting Coronary Stent System Production Capacity, 2018-2029
8.2 Drug-Eluting Coronary Stent System Production Capacity of Key Manufacturers in Global Market
8.3 Global Drug-Eluting Coronary Stent System Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Drug-Eluting Coronary Stent System Supply Chain Analysis
10.1 Drug-Eluting Coronary Stent System Industry Value Chain
10.2 Drug-Eluting Coronary Stent System Upstream Market
10.3 Drug-Eluting Coronary Stent System Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Drug-Eluting Coronary Stent System Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Drug-Eluting Coronary Stent System in Global Market
Table 2. Top Drug-Eluting Coronary Stent System Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Drug-Eluting Coronary Stent System Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Drug-Eluting Coronary Stent System Revenue Share by Companies, 2018-2023
Table 5. Global Drug-Eluting Coronary Stent System Sales by Companies, (K Units), 2018-2023
Table 6. Global Drug-Eluting Coronary Stent System Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Drug-Eluting Coronary Stent System Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Drug-Eluting Coronary Stent System Product Type
Table 9. List of Global Tier 1 Drug-Eluting Coronary Stent System Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Drug-Eluting Coronary Stent System Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Drug-Eluting Coronary Stent System Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Drug-Eluting Coronary Stent System Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Drug-Eluting Coronary Stent System Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Drug-Eluting Coronary Stent System Sales (K Units), 2018-2023
Table 15. By Type - Global Drug-Eluting Coronary Stent System Sales (K Units), 2024-2029
Table 16. By Application – Global Drug-Eluting Coronary Stent System Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Drug-Eluting Coronary Stent System Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Drug-Eluting Coronary Stent System Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Drug-Eluting Coronary Stent System Sales (K Units), 2018-2023
Table 20. By Application - Global Drug-Eluting Coronary Stent System Sales (K Units), 2024-2029
Table 21. By Region – Global Drug-Eluting Coronary Stent System Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Drug-Eluting Coronary Stent System Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Drug-Eluting Coronary Stent System Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Drug-Eluting Coronary Stent System Sales (K Units), 2018-2023
Table 25. By Region - Global Drug-Eluting Coronary Stent System Sales (K Units), 2024-2029
Table 26. By Country - North America Drug-Eluting Coronary Stent System Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Drug-Eluting Coronary Stent System Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Drug-Eluting Coronary Stent System Sales, (K Units), 2018-2023
Table 29. By Country - North America Drug-Eluting Coronary Stent System Sales, (K Units), 2024-2029
Table 30. By Country - Europe Drug-Eluting Coronary Stent System Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Drug-Eluting Coronary Stent System Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Drug-Eluting Coronary Stent System Sales, (K Units), 2018-2023
Table 33. By Country - Europe Drug-Eluting Coronary Stent System Sales, (K Units), 2024-2029
Table 34. By Region - Asia Drug-Eluting Coronary Stent System Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Drug-Eluting Coronary Stent System Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Drug-Eluting Coronary Stent System Sales, (K Units), 2018-2023
Table 37. By Region - Asia Drug-Eluting Coronary Stent System Sales, (K Units), 2024-2029
Table 38. By Country - South America Drug-Eluting Coronary Stent System Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Drug-Eluting Coronary Stent System Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Drug-Eluting Coronary Stent System Sales, (K Units), 2018-2023
Table 41. By Country - South America Drug-Eluting Coronary Stent System Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Drug-Eluting Coronary Stent System Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Drug-Eluting Coronary Stent System Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Drug-Eluting Coronary Stent System Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Drug-Eluting Coronary Stent System Sales, (K Units), 2024-2029
Table 46. Medtronic Company Summary
Table 47. Medtronic Drug-Eluting Coronary Stent System Product Offerings
Table 48. Medtronic Drug-Eluting Coronary Stent System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Medtronic Key News & Latest Developments
Table 50. Abbott Company Summary
Table 51. Abbott Drug-Eluting Coronary Stent System Product Offerings
Table 52. Abbott Drug-Eluting Coronary Stent System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Abbott Key News & Latest Developments
Table 54. Cook Medical Company Summary
Table 55. Cook Medical Drug-Eluting Coronary Stent System Product Offerings
Table 56. Cook Medical Drug-Eluting Coronary Stent System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Cook Medical Key News & Latest Developments
Table 58. Biotronik Company Summary
Table 59. Biotronik Drug-Eluting Coronary Stent System Product Offerings
Table 60. Biotronik Drug-Eluting Coronary Stent System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Biotronik Key News & Latest Developments
Table 62. Terumo Company Summary
Table 63. Terumo Drug-Eluting Coronary Stent System Product Offerings
Table 64. Terumo Drug-Eluting Coronary Stent System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Terumo Key News & Latest Developments
Table 66. Boston Scientific Company Summary
Table 67. Boston Scientific Drug-Eluting Coronary Stent System Product Offerings
Table 68. Boston Scientific Drug-Eluting Coronary Stent System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Boston Scientific Key News & Latest Developments
Table 70. B. Braun Company Summary
Table 71. B. Braun Drug-Eluting Coronary Stent System Product Offerings
Table 72. B. Braun Drug-Eluting Coronary Stent System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. B. Braun Key News & Latest Developments
Table 74. STENTYS SA Company Summary
Table 75. STENTYS SA Drug-Eluting Coronary Stent System Product Offerings
Table 76. STENTYS SA Drug-Eluting Coronary Stent System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. STENTYS SA Key News & Latest Developments
Table 78. MicroPort Company Summary
Table 79. MicroPort Drug-Eluting Coronary Stent System Product Offerings
Table 80. MicroPort Drug-Eluting Coronary Stent System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. MicroPort Key News & Latest Developments
Table 82. Cordis Company Summary
Table 83. Cordis Drug-Eluting Coronary Stent System Product Offerings
Table 84. Cordis Drug-Eluting Coronary Stent System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Cordis Key News & Latest Developments
Table 86. BD Company Summary
Table 87. BD Drug-Eluting Coronary Stent System Product Offerings
Table 88. BD Drug-Eluting Coronary Stent System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. BD Key News & Latest Developments
Table 90. Sorin Group Company Summary
Table 91. Sorin Group Drug-Eluting Coronary Stent System Product Offerings
Table 92. Sorin Group Drug-Eluting Coronary Stent System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. Sorin Group Key News & Latest Developments
Table 94. SMT Company Summary
Table 95. SMT Drug-Eluting Coronary Stent System Product Offerings
Table 96. SMT Drug-Eluting Coronary Stent System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. SMT Key News & Latest Developments
Table 98. LifeTech Scientific Corporation Company Summary
Table 99. LifeTech Scientific Corporation Drug-Eluting Coronary Stent System Product Offerings
Table 100. LifeTech Scientific Corporation Drug-Eluting Coronary Stent System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 101. LifeTech Scientific Corporation Key News & Latest Developments
Table 102. Lepu Medical Technology(Beijing)Co.,Ltd. Company Summary
Table 103. Lepu Medical Technology(Beijing)Co.,Ltd. Drug-Eluting Coronary Stent System Product Offerings
Table 104. Lepu Medical Technology(Beijing)Co.,Ltd. Drug-Eluting Coronary Stent System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 105. Lepu Medical Technology(Beijing)Co.,Ltd. Key News & Latest Developments
Table 106. JW Medical Systems LTD. Company Summary
Table 107. JW Medical Systems LTD. Drug-Eluting Coronary Stent System Product Offerings
Table 108. JW Medical Systems LTD. Drug-Eluting Coronary Stent System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 109. JW Medical Systems LTD. Key News & Latest Developments
Table 110. Sino Medical Sciences Technology Inc. Company Summary
Table 111. Sino Medical Sciences Technology Inc. Drug-Eluting Coronary Stent System Product Offerings
Table 112. Sino Medical Sciences Technology Inc. Drug-Eluting Coronary Stent System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 113. Sino Medical Sciences Technology Inc. Key News & Latest Developments
Table 114. Drug-Eluting Coronary Stent System Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 115. Global Drug-Eluting Coronary Stent System Capacity Market Share of Key Manufacturers, 2021-2023
Table 116. Global Drug-Eluting Coronary Stent System Production by Region, 2018-2023 (K Units)
Table 117. Global Drug-Eluting Coronary Stent System Production by Region, 2024-2029 (K Units)
Table 118. Drug-Eluting Coronary Stent System Market Opportunities & Trends in Global Market
Table 119. Drug-Eluting Coronary Stent System Market Drivers in Global Market
Table 120. Drug-Eluting Coronary Stent System Market Restraints in Global Market
Table 121. Drug-Eluting Coronary Stent System Raw Materials
Table 122. Drug-Eluting Coronary Stent System Raw Materials Suppliers in Global Market
Table 123. Typical Drug-Eluting Coronary Stent System Downstream
Table 124. Drug-Eluting Coronary Stent System Downstream Clients in Global Market
Table 125. Drug-Eluting Coronary Stent System Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Drug-Eluting Coronary Stent System Segment by Type in 2022
Figure 2. Drug-Eluting Coronary Stent System Segment by Application in 2022
Figure 3. Global Drug-Eluting Coronary Stent System Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Drug-Eluting Coronary Stent System Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Drug-Eluting Coronary Stent System Revenue, 2018-2029 (US$, Mn)
Figure 7. Drug-Eluting Coronary Stent System Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Drug-Eluting Coronary Stent System Revenue in 2022
Figure 9. By Type - Global Drug-Eluting Coronary Stent System Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Drug-Eluting Coronary Stent System Revenue Market Share, 2018-2029
Figure 11. By Type - Global Drug-Eluting Coronary Stent System Sales Market Share, 2018-2029
Figure 12. By Type - Global Drug-Eluting Coronary Stent System Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Drug-Eluting Coronary Stent System Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Drug-Eluting Coronary Stent System Revenue Market Share, 2018-2029
Figure 15. By Application - Global Drug-Eluting Coronary Stent System Sales Market Share, 2018-2029
Figure 16. By Application - Global Drug-Eluting Coronary Stent System Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Drug-Eluting Coronary Stent System Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Drug-Eluting Coronary Stent System Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Drug-Eluting Coronary Stent System Revenue Market Share, 2018-2029
Figure 20. By Region - Global Drug-Eluting Coronary Stent System Sales Market Share, 2018-2029
Figure 21. By Country - North America Drug-Eluting Coronary Stent System Revenue Market Share, 2018-2029
Figure 22. By Country - North America Drug-Eluting Coronary Stent System Sales Market Share, 2018-2029
Figure 23. US Drug-Eluting Coronary Stent System Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Drug-Eluting Coronary Stent System Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Drug-Eluting Coronary Stent System Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Drug-Eluting Coronary Stent System Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Drug-Eluting Coronary Stent System Sales Market Share, 2018-2029
Figure 28. Germany Drug-Eluting Coronary Stent System Revenue, (US$, Mn), 2018-2029
Figure 29. France Drug-Eluting Coronary Stent System Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Drug-Eluting Coronary Stent System Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Drug-Eluting Coronary Stent System Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Drug-Eluting Coronary Stent System Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Drug-Eluting Coronary Stent System Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Drug-Eluting Coronary Stent System Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Drug-Eluting Coronary Stent System Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Drug-Eluting Coronary Stent System Sales Market Share, 2018-2029
Figure 37. China Drug-Eluting Coronary Stent System Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Drug-Eluting Coronary Stent System Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Drug-Eluting Coronary Stent System Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Drug-Eluting Coronary Stent System Revenue, (US$, Mn), 2018-2029
Figure 41. India Drug-Eluting Coronary Stent System Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Drug-Eluting Coronary Stent System Revenue Market Share, 2018-2029
Figure 43. By Country - South America Drug-Eluting Coronary Stent System Sales Market Share, 2018-2029
Figure 44. Brazil Drug-Eluting Coronary Stent System Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Drug-Eluting Coronary Stent System Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Drug-Eluting Coronary Stent System Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Drug-Eluting Coronary Stent System Sales Market Share, 2018-2029
Figure 48. Turkey Drug-Eluting Coronary Stent System Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Drug-Eluting Coronary Stent System Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Drug-Eluting Coronary Stent System Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Drug-Eluting Coronary Stent System Revenue, (US$, Mn), 2018-2029
Figure 52. Global Drug-Eluting Coronary Stent System Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Drug-Eluting Coronary Stent System by Region, 2022 VS 2029
Figure 54. Drug-Eluting Coronary Stent System Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 薬剤溶出型冠動脈ステントシステムのグローバル市場展望 2023年-2029年：非生分解性ステント、生分解性ステント(Drug-Eluting Coronary Stent System Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

薬剤溶出型冠動脈ステントシステムのグローバル市場展望 2023年-2029年：非生分解性ステント、生分解性ステント

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp